Product Information
FLUVOXAMINE ER 150 MG CAPSULE is a generic product labeled by Endo USA Inc., priced at $4.9611 per EA under NDC 10370017611. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
150 mg/1
Manufacturer
Endo USA Inc.NDC
10370017611
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FLUVOXAMINE MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA091476On Market Since
3/13/2013
Pharmacological Classes
Price Statistics
The NADAC for FLUVOXAMINE ER 150 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 34.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.9611 per EA |
|---|---|
| All-time high | $8.9551 (Sep 10, 2014) |
| All-time low | $3.6682 (Jul 17, 2024) |
| 52-week high | $5.6209 |
| 52-week low | $4.7857 |
| Median price | $6.7671 |
| Average price | $6.6084 |
| Largest weekly change | -33.5% (Apr 17, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FLUVOXAMINE ER 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FLUVOXAMINE ER 150 MG CAPSULE, manufactured by Endo USA Inc., is $4.9611 per EA (NDC 10370017611), effective Jun 24, 2026.
How has the price of FLUVOXAMINE ER 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FLUVOXAMINE ER 150 MG CAPSULE has declined 34.6%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FLUVOXAMINE ER 150 MG CAPSULE?
Since Nov 28, 2013, the NADAC for FLUVOXAMINE ER 150 MG CAPSULE has ranged from a low of $3.6682 (Jul 17, 2024) to a high of $8.9551 (Sep 10, 2014), with a median of $6.7671 per EA.
Are there cheaper alternatives to FLUVOXAMINE ER 150 MG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as FLUVOXAMINE ER 150 MG CAPSULE, but none are currently priced below it.
Who manufactures FLUVOXAMINE ER 150 MG CAPSULE?
FLUVOXAMINE ER 150 MG CAPSULE (NDC 10370017611) is labeled by Endo USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification